L773:1462 0332 OR L773:1460 2172
Search: L773:1462 0332 OR L773:1460 2172 > (2000-2004) > The cost-effectiven...
- 23 of 39
- Previous record
- Next record
- To hitlist
The cost-effectiveness of infliximab (Remicade((R))) in the treatment of rheumatoid arthritis in Sweden and the United Kingdom based on the ATTRACT study.
- Kobelt, G (author)
-
- Jönsson, L (author)
- Karolinska Institutet
- Young, A (author)
- show more...
- show less...
- (creator_code:org_t)
- 2003-02
- 2003
- English.
- In: Rheumatology. - : Oxford University Press (OUP). - 1462-0332 .- 1462-0324. ; 42:2, s. 326-335
- Journal article (peer-reviewed)
Subject headings
Close
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Reumatologi och inflammation (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Rheumatology and Autoimmunity (hsv//eng)
Publication and Content Type
- art (subject category)
- ref (subject category)
- 23 of 39
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Kobelt, G
- Jönsson, L
- Young, A
- Eberhardt, Kerst ...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Rheumatology and ...
- Articles in the publication
- Rheumatology
- By the university
- Lund University
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
